Purpose Gallbladder diseases and cholecystectomy may play a role in the development of colorectal cancer (CRC). Our aim was to investigate the association between cholecystectomy and CRC risk overall and by sex, family history, anatomical location, and tumor mismatch repair (MMR) status. Methods This study comprised 5847 incident CRC cases recruited from population cancer registries in Australia, Canada, and the USA into the Colon Cancer Family Registry between 1997 and 2012 and 4970 controls with no personal history of CRC who were either randomly selected from the general population or were spouses of the cases. The association between cholecystectomy and CRC was estimated using logistic regression, after adjusting for confounding factors.
Introduction
Colorectal cancer (CRC) accounts for 10 % of all cancer incidence and is the fourth ranking cause of cancer mortality worldwide [1] . In 2012, 746,000 men and 614,000 women were diagnosed with CRC globally, with highly industrialized and urbanized societies (including North America, most European countries, Japan, and Australia) contributing to more than half. Identifying risk factors associated with CRC may inform strategies to prevent and detect cancers at an early stage. Certain medical conditions and interventions may play a role in the development of CRC [2] .
Gallbladder diseases such as gallstones which lead to gallbladder inflammation (cholecystitis) are highly prevalent in Western populations [3, 4] . The lifetime risk of developing gallstones in Western populations is between 5 and 25 %, and women in the USA under 40 years of age are at nearly twice the risk of developing gallstones than men [5] . The common treatment for inflammatory gallstones, cholecystectomy, has the potential to lead to increased bile exposure in the colon and rectum. Bile acids cause DNA damage probably indirectly through the induction of oxidative stress and the production of reactive oxygen species. Excessive DNA damage may cause genetic instability and increase mutations of tumor suppressor genes and oncogenes, subsequently increasing the risk of CRC [6] .
Previous studies have reported conflicting results on associations between gallstones and/or cholecystectomy and CRC [7, 8] or colorectal adenoma [9] . Further, risks may be differentially associated with cancer at different anatomical locations within the colon [10] . No previous studies have examined the association between cholecystectomy and CRC according to their tumor mismatch repair (MMR) status. Here, we investigated associations between cholecystectomy and CRC risk by sex, family history, anatomical location, and tumor MMR status.
Materials and methods

Study sample
This study was designed as a retrospective case-control study. Cases were individuals diagnosed with incident colon or rectal cancer who were recruited through population cancer registries from four centers of the Colon Cancer Family Registry between 1997 and 2012, Cancer Care Ontario (Toronto, Canada), Fred Hutchinson Cancer Research Center (Seattle, USA), Mayo Clinic (Rochester, USA), and The University of Melbourne (Melbourne, Australia) [11] . We only included cases interviewed by staff from the Colon Cancer Family Registry within 5 years of diagnosis. Controls were either individuals with no personal history of CRC who were recruited randomly from the general population through Medicare and Driver's License files, telephone subscribers lists, electoral rolls, or the CRC cases' spouses with no personal history of CRC. For all participants, we excluded those without information on whether or not they had cholecystectomy.
Data collection
We collected data on demographic information, personal and familial history of CRC, medical history including surgeries, medical conditions, and drug use, alcohol intake, smoking status for all participants, and reproductive history for women at the time of baseline recruitment. Uniform questionnaires (http://coloncfr.org/questionnaires) were used to acquire data by telephone interviews (Fred Hutchinson Cancer Research Center, University of Melbourne, and Mayo Clinic) and mails (Cancer Care Ontario and Mayo Clinic). All participants were asked whether or not they had surgical removal of their gallbladder and if so, at what age they were at the time of the removal.
Tumor molecular characterization
CRCs were characterized for MMR deficiency by microsatellite instability (MSI) using a ten-marker panel (four mononucleotide markers (BAT25, BAT26, BAT40, and BAT34C4), five dinucleotide markers (D5S346, D17S250, ACTC, D18S55, and D10S197), and one penta-mono-tetra compound-repeat marker (MYCL)) and/or by immunohistochemistry (IHC) for the four MMR proteins. Tumors were classified as MMR deficient if they were MSI high (≥30 % unstable markers) and/ or showed loss of expression of one or more of the MMR proteins by IHC and MMR proficient if they were microsatellite stable (no unstable markers) or MSI low (<30 % unstable markers) and/or showed normal expression of all four MMR proteins by IHC [11] .
Statistical analysis
Odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for the association between cholecystectomy and CRC were estimated using multivariable unconditional logistic regression. We estimated the associations stratified by sex, first-degree family history, anatomical location, and tumor MMR status. We investigated potential interactions between cholecystectomy status and age at study recruitment (≤45, 45-55, 55-65, and >65 years), sex, recent body mass index (BMI), and BMI at age 20 years (underweight, normal, overweight, and obese) using likelihood ratio tests comparing the results with and without the interaction terms in the logistic regression models.
To investigate whether the time since cholecystectomy was associated with CRC risk for the participants that had undergone cholecystectomy, we compared the mean of time since cholecystectomy between cases (age at CRC diagnosis minus age at cholecystectomy) and controls (age at study recruitment minus age at cholecystectomy) using a multivariable linear regression model. Some centers of the Colon Cancer Family Registry used stratified sampling based on family history for recruitment, and we did take this into account when combining and analyzing the data. To adjust for the stratified sampling, we gave each individual a probability weight equal to the reciprocal of the family sampling fraction. All statistical analyses were conducted using STATA version 13.0 (StataCorp, College Station, TX).
Results
This study comprised 5847 pathologically confirmed CRC cases and 4243 population-based controls and 727 spouse controls ( Fig. 1 ). Baseline characteristics of cases and controls are presented in Table 1 .
In total, 521 (8.9 %) cases and 555 (11.2 %) controls had undergone cholecystectomy. Overall, there was no evidence for an association between cholecystectomy and CRC (OR = 0.88, 95 % CI 0.73, 1.08) after adjusting for confounding factors. In stratified analyses, there was no evidence for a difference in the association between women and men (P = 0.54), between individuals with and without a family history of CRC in first-degree relative (P = 0.64), between tumor anatomical locations (P = 0.45), or between MMRproficient and MMR-deficient cases (P = 0.54) ( Table 2 ). There was no evidence for interactions between cholecystectomy status and age at study recruitment, sex, recent BMI, and BMI at age 20 years (details not shown).
Moreover, there was no evidence for a difference in the time since cholecystectomy between cases and controls (14.5 (SD 12.1) years vs. 15 (SD 11.6) years; mean difference −0.0003, 95% CI −0.004, 0.003 years, P = 0.86), after adjusting for confounding factors.
Discussion
We found no evidence for an association between cholecystectomy and CRC risk, overall or by sex, first-degree family history of CRC, anatomical location, or tumor MMR status. This study is the first to examine the association according to tumor MMR status.
Although a few studies have reported a positive association between cholecystectomy and CRC risk [12, 13] , previous meta-analyses have reported that cholecystectomy was not associated with the risk of proximal colon cancer [7] , rectal cancer [8] , or colorectal adenoma [9] . However, most of the previous studies adjusted only for age and sex [10] . In our current study, we adequately adjusted for additional important confounding factors such as obesity, diabetes, and family history.
The strengths of our study include large sample size and high-quality data of the Colon Cancer Family Registry, which employs standardized protocols for data and biospecimens collection [11] . One limitation of our study is the possibility of recall bias because cholecystectomy information was selfreported and not validated by medical records. However, a previous study reported 99.6 % agreement between self- report and medical records for cholecystectomy [14] . Further, given approximately 90 % of our study participants are Caucasians from developed countries, the study results may not be applicable to other populations.
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